Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunologic effects of AS101 in the treatment of cancer patients.
Shani A, Tichler T, Catane R, Gurwith M, Rozenszajn LA, Gezin A, Levi E, Schlesinger M, Kalechman Y, Michlin H, et al. Shani A, et al. Nat Immun Cell Growth Regul. 1990;9(3):182-90. Nat Immun Cell Growth Regul. 1990. PMID: 2370878
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
Ron IG, Wigler N, Borovik R, Brufman G, Rizel S, Shani A, Brenner J, Farbstein H, Dale A, Inbar MJ, Brenner HJ, Chaitchik S, Catane R. Ron IG, et al. Among authors: shani a. Am J Clin Oncol. 2001 Aug;24(4):323-7. doi: 10.1097/00000421-200108000-00001. Am J Clin Oncol. 2001. PMID: 11474254 Clinical Trial.
Clinical aspects of ovarian tumors of low malignant potential.
Dgani R, Blickstein I, Shoham Z, Czernobilsky B, Ben-Hur H, Shani A, Katz Z, Borenstein R. Dgani R, et al. Among authors: shani a. Eur J Obstet Gynecol Reprod Biol. 1990 May-Jun;35(2-3):251-8. doi: 10.1016/0028-2243(90)90169-2. Eur J Obstet Gynecol Reprod Biol. 1990. PMID: 2159428
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Sredni B, Xu RH, Albeck M, Gafter U, Gal R, Shani A, Tichler T, Shapira J, Bruderman I, Catane R, Kaufman B, Whisnant JK, Mettinger KL, Kalechman Y. Sredni B, et al. Among authors: shani a. Int J Cancer. 1996 Jan 3;65(1):97-103. doi: 10.1002/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F. Int J Cancer. 1996. PMID: 8543404 Free article. Clinical Trial.
125 results